Factors associated with parathyroid hormone control in haemodialysis patients with secondary hyperparathyroidism treated with cinacalcet in real-world clinical practice: Mimosa study

Autor: Pablo Ureña-Torres, Jacques Rottembourg, Abdelaziz Hamani, Daniel Toledano, Corinne Emery, Victor Gueutin, Hedia Hebibi, Olivier Coldefy, Thomas Guincestre

Publikováno v: Clinical Kidney Journal

Background Secondary hyperparathyroidism (SHPT) is frequent in haemodialysis (HD) patients. Oral cinacalcet-hydrochloride (HCl) decreases parathyroid hormone (PTH); however, real-life PTH data, according to Kidney Disease: Improving Global Outcomes (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eff1e2d1e4e85efd2dab190dcf103c8
https://doi.org/10.1093/ckj/sfz021

Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational study

Autor: Linda H. Ficociello, Jacques Rottembourg, Amandine Perrin, Sebastian Walpen, Philip A. Kalra, Christoph Wanner, Manuela Stauss-Grabo, Denis Fouque, Jorge B. Cannata-Andía, Angel L.M. de Francisco, Marc G. Vervloet, Markus Ketteler, Piergiorgio Messa, Anja Derlet, Ioannis N Boletis

Publikováno v: Clinical Kidney Journal
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
Clinical Kidney Journal, Oxford University Press, 2021, 14 (7), pp.1770-1779. ⟨10.1093/ckj/sfaa211⟩

Background The iron-based phosphate binder (PB), sucroferric oxyhydroxide (SFOH), is indicated to control serum phosphorus levels in patients with chronic kidney disease on dialysis. Methods This non-interventional, prospective, multicentre, cohort s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a66ac69eeed6e610535976ab8ef64b3c
https://pubmed.ncbi.nlm.nih.gov/34221384

Are oxyphil cells responsible for the ineffectiveness of cinacalcet hydrochloride in haemodialysis patients?

Autor: Jacques Rottembourg, Fabrice Menegaux

Publikováno v: Clinical Kidney Journal
Clinical Kidney Journal, Oxford University Press, 2019, 12 (3), pp.433-436. ⟨10.1093/ckj/sfy062⟩

International audience; Parathyroid glands consist primarily of chief cells. In some cases, the proportion of parathyroid oxyphil cells increases in patients with chronic kidney disease. We describe a case of secondary hyperparathyroidism (SHPT) in a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe3c4143c298de213f8f89e18588573c
http://europepmc.org/articles/PMC6543953

Athérome et insuffisance rénale : la revascularisation peut-elle améliorer la fonction rénale ?

Autor: Jacques Rottembourg

Publikováno v: Bulletin de l'Académie Nationale de Médecine. 201:1377-1384

RESUME Le vieillissement de la population et le developpement de l’atherome a entraine une augmentation de la prevalence de la maladie reno-vasculaire atheromateuse. Le traitement medical et la prise en charge globale s’est amelioree au cours des

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2d9a44cd1288088fb90901c5a2561df9
https://doi.org/10.1016/s0001-4079(19)30399-1

Clinical hemodialysis experience with percutaneous arteriovenous fistulas created using the Ellipsys® vascular access system

Autor: Hedia Hebibi, Gilbert Franco, Jedjiga Achiche, Jacques Rottembourg

Publikováno v: Hemodialysis International. International Symposium on Home Hemodialysis

Introduction: The aim of this study is to report our clinical hemodialysis experience using a percutaneous arteriovenous fistula (pAVF) created with the Ellipsys® vascular access system. This pAVF device creates a permanent AVF anastomosis between t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d74a86757673393c084833b279cd75b
https://pubmed.ncbi.nlm.nih.gov/30821894